- Home
- MTVA vs ABVE Comparison
MTVA vs ABVE Comparison
Compare MTVA & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- ABVE
- Stock Information
- Founded
- MTVA 2014
- ABVE 2019
- Country
- MTVA United States
- ABVE Canada
- Employees
- MTVA N/A
- ABVE N/A
- Industry
- MTVA
- ABVE Packaged Foods
- Sector
- MTVA
- ABVE Consumer Staples
- Exchange
- MTVA NYSE
- ABVE Nasdaq
- Market Cap
- MTVA 18.9M
- ABVE 18.0M
- IPO Year
- MTVA N/A
- ABVE N/A
- Fundamental
- Price
- MTVA $1.85
- ABVE $0.51
- Analyst Decision
- MTVA
- ABVE
- Analyst Count
- MTVA 0
- ABVE 0
- Target Price
- MTVA N/A
- ABVE N/A
- AVG Volume (30 Days)
- MTVA 256.5K
- ABVE 828.4K
- Earning Date
- MTVA 11-07-2024
- ABVE 02-15-2025
- Dividend Yield
- MTVA N/A
- ABVE N/A
- EPS Growth
- MTVA N/A
- ABVE N/A
- EPS
- MTVA N/A
- ABVE N/A
- Revenue
- MTVA N/A
- ABVE $275,376,450.00
- Revenue This Year
- MTVA N/A
- ABVE N/A
- Revenue Next Year
- MTVA N/A
- ABVE N/A
- P/E Ratio
- MTVA N/A
- ABVE N/A
- Revenue Growth
- MTVA N/A
- ABVE N/A
- 52 Week Low
- MTVA $1.55
- ABVE $0.34
- 52 Week High
- MTVA $6.75
- ABVE $4.07
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- ABVE N/A
- Support Level
- MTVA N/A
- ABVE N/A
- Resistance Level
- MTVA N/A
- ABVE N/A
- Average True Range (ATR)
- MTVA 0.00
- ABVE 0.00
- MACD
- MTVA 0.00
- ABVE 0.00
- Stochastic Oscillator
- MTVA 0.00
- ABVE 0.00
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.